Ursodeoxycholic acid treatment in cystic fibrosis-associated liver disease

被引：0
|
作者：
Colombo, C [1 ]
Comi, S [1 ]
Moretti, E [1 ]
机构：
[1] Univ Sassari, Dept Pediat, I-01700 Sassari, Italy
来源：
BIOLOGY OF BILE ACIDS IN HEALTH AND DISEASE | 2001年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：311 / 316
页数：6
相关论文
共 50 条
  • [1] Ursodeoxycholic acid in cystic fibrosis-associated liver disease
    Ooi, Chee Y.
    Nightingale, Scott
    Durie, Peter R.
    Freedman, Steven D.
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (01) : 72 - 73
  • [2] Ursodeoxycholic acid in cystic fibrosis-associated liver disease Response
    Colombo, Carla
    Debray, Dominique
    Kelly, Deirdre
    Houwen, Roderick
    Battezzati, Pier Maria
    Strandvik, Birgitta
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (01) : 74 - 75
  • [3] URSODEOXYCHOLIC ACID FOR CYSTIC FIBROSIS-ASSOCIATED LIVER-DISEASE - FINAL REPORT OF A MULTICENTER TRIAL
    COLOMBO, C
    PODDA, M
    BATTEZZATI, PM
    SANTINI, B
    IAPICHINO, L
    QUATTRUCCI, S
    LUCIDI, V
    FERRARI, R
    SCOTTA, S
    MINICUCCI, L
    CANDUSSO, M
    VALLETTA, E
    GAGLIARDINI, R
    SANTAMARIA, F
    BATTISTINI, F
    GIUNTA, A
    HEPATOLOGY, 1993, 18 (04) : A142 - A142
  • [4] Cystic fibrosis-associated liver disease
    Herrmann, Ulrike
    Dockter, Gerd
    Lammert, Frank
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2010, 24 (05) : 585 - 592
  • [5] Markers of cystic fibrosis-associated liver disease
    Narkewicz, MR
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 32 (04): : 421 - 422
  • [6] Cystic fibrosis-associated liver disease in children
    Wasuwanich, Paul
    Karnsakul, Wikrom
    MINERVA PEDIATRICA, 2020, 72 (05) : 440 - 447
  • [7] URSODEOXYCHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVEMENT OF LIVER STIFFNESS IN CYSTIC FIBROSIS RELATED LIVER DISEASE
    Lamers, C. R.
    van der Feen, C.
    van der Doef, H. P.
    van der Ent, C. K.
    Houwen, R. H.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 426 - 426
  • [8] Abnormalities in biliary drainage may predict a better response to ursodeoxycholic acid in cystic fibrosis-associated liver disease.
    Colombo, C
    Castellani, MR
    Crosignani, A
    Comi, S
    Giunta, A
    HEPATOLOGY, 1996, 24 (04) : 298 - 298
  • [9] Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease
    Colombo, C
    Crosignani, A
    Battezzati, PM
    Castellani, MR
    Comi, S
    Melzi, ML
    Giunta, A
    JOURNAL OF HEPATOLOGY, 1999, 31 (04) : 672 - 677
  • [10] Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease
    Siano, Maria
    De Gregorio, Fabiola
    Boggia, Bartolo
    Sepe, Angela
    Ferri, Pasqualina
    Buonpensiero, Paolo
    Di Pasqua, Antonio
    Raia, Valeria
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (06) : 428 - 431
12345